African Journal of Infectious Diseases Research

ISSN 2756-3340

Table of Contents 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 621–627

DOI: 10.46882/AJIDR/148852

Article Type: Original Article

Title: Prevalence and clinical correlates of Pneumocystis jirovecii pneumonia among hospitalized HIV-infected adults with acute respiratory distress

Names of Authors: Thandeka Zulu¹*, Henri Moreau²

Authors’ Affiliations: ¹Department of Pulmonology, University of Pretoria, Pretoria, South Africa. ²Department of Mycology, University of Strasbourg, Strasbourg, France.

Abstract: Pneumocystis jirovecii pneumonia remains a life-threatening opportunistic fungal infection among individuals presenting with advanced HIV disease. We evaluated the prevalence, radiological patterns, and mortality predictors of P. jirovecii pneumonia among hypoxic HIV-positive admissions. Induced sputum and bronchoalveolar lavage specimens from 210 patients were examined via immunofluorescence microscopy and quantitative real-time polymerase chain reaction. P. jirovecii was confirmed in 33.8 percent of patients, strongly associated with CD4 counts below 100 cells per microliter and lack of cotrimoxazole prophylaxis. Elevated serum lactate dehydrogenase and severe hypoxemia independently predicted in-hospital mortality.

Keywords: Pneumocystis jirovecii, HIV/AIDS, Opportunistic pneumonia, Fungal diagnostics, Cotrimoxazole prophylaxis

Citation: Zulu T, Moreau H (2025). Prevalence and clinical correlates of Pneumocystis jirovecii pneumonia among hospitalized HIV-infected adults with acute respiratory distress. African Journal of Infectious Diseases Research, 12(8): 621–627. DOI: 10.46882/AJIDR/148852

Manuscript Timeline: Received: June 19, 2025; Revised: July 20, 2025; Accepted: August 02, 2025; Published: August 06, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 614–620

DOI: 10.46882/AJIDR/148851

Article Type: Research Article

Title: Molecular epidemiology and antimicrobial resistance of Shigella species isolated from children under five with acute dysentery

Names of Authors: Chukwudi Nwankwo¹*, Freja Holm², Siddharth Iyer³

Authors’ Affiliations: ¹Department of Medical Microbiology, University of Nigeria, Nsukka, Nigeria. ²Department of Clinical Microbiology, University of Copenhagen, Copenhagen, Denmark. ³Department of Enteric Diseases, National Institute of Cholera and Enteric Diseases, Kolkata, India.

Abstract: Shigellosis remains a leading bacterial cause of inflammatory diarrhea and childhood morbidity in low-resource settings. We determined the species distribution, virulence gene profiles, and antibiotic resistance patterns of Shigella isolates recovered from pediatric dysentery cases. Stool samples from 430 children presenting with bloody mucoid diarrhea were cultured on selective media and analyzed via multiplex polymerase chain reaction. Shigella flexneri and Shigella sonnei accounted for 61.3 percent and 28.0 percent of confirmed isolates, respectively. High resistance to ampicillin, trimethoprim-sulfamethoxazole, and ciprofloxacin was observed, while ceftriaxone and azithromycin retained strong activity.

Keywords: Shigellosis, Shigella flexneri, Pediatric dysentery, Antimicrobial resistance, Enteric pathogens

Citation: Nwankwo C, Holm F, Iyer S (2025). Molecular epidemiology and antimicrobial resistance of Shigella species isolated from children under five with acute dysentery. African Journal of Infectious Diseases Research, 12(8): 614–620. DOI: 10.46882/AJIDR/148851

Manuscript Timeline: Received: June 15, 2025; Revised: July 17, 2025; Accepted: July 30, 2025; Published: August 03, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 607–613

DOI: 10.46882/AJIDR/148850

Article Type: Original Article

Title: Seroepidemiology and clinical severity of Chikungunya virus infection during an acute febrile arthralgia outbreak

Names of Authors: Miriam Nabwire¹*, Henrik Lindstrom², Rafael Mendoza³

Authors’ Affiliations: ¹Department of Medical Microbiology, Makerere University, Kampala, Uganda. ²Department of Clinical Virology, University of Helsinki, Helsinki, Finland. ³Department of Tropical Medicine, Cayetano Heredia University, Lima, Peru.

Abstract: Chikungunya virus causes explosive outbreaks of acute febrile illness accompanied by debilitating polyarthralgia that can persist for months. We investigated the laboratory confirmation rate, clinical manifestations, and persistent joint pain predictors among outbreak patients. Serum samples from 415 patients presenting with acute fever and severe arthralgia were tested via real-time reverse transcription polymerase chain reaction and anti-Chikungunya IgM enzyme-linked immunosorbent assay. Acute Chikungunya infection was confirmed in 39.8 percent of cases, with symmetrical wrist and ankle arthritis, maculopapular rash, and myalgia predominating. Older age and high baseline viremia predicted chronic arthralgia at three months.

Keywords: Chikungunya virus, Arbovirus outbreak, Polyarthralgia, Febrile illness, Molecular surveillance

Citation: Nabwire M, Lindstrom H, Mendoza R (2025). Seroepidemiology and clinical severity of Chikungunya virus infection during an acute febrile arthralgia outbreak. African Journal of Infectious Diseases Research, 12(8): 607–613. DOI: 10.46882/AJIDR/148850

Manuscript Timeline: Received: July 10, 2025; Revised: August 11, 2025; Accepted: August 22, 2025; Published: August 31, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 600–606

DOI: 10.46882/AJIDR/148849

Article Type: Research Article

Title: Molecular identification and drug susceptibility patterns of nontuberculous mycobacteria isolated from patients with presumptive pulmonary tuberculosis

Names of Authors: Boitumelo Moloi¹*, Rachelle Tremblay², Jae-Hyun Lim³

Authors’ Affiliations: ¹Department of Medical Microbiology, Sefako Makgatho Health Sciences University, Pretoria, South Africa. ²Department of Medicine, McGill University, Montreal, Canada. ³Department of Laboratory Medicine, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Abstract: Nontuberculous mycobacteria increasingly cause chronic pulmonary disease that clinically and radiographically mimics Mycobacterium tuberculosis, leading to inappropriate empiric therapy. We determined the species diversity and antimicrobial susceptibility of nontuberculous mycobacteria isolated from smear-positive, Xpert-negative sputum specimens. A total of 112 mycobacterial culture isolates were identified via line probe assays and rpoB gene sequencing alongside broth microdilution susceptibility testing. Mycobacterium avium complex and Mycobacterium abscessus accounted for 48.2 percent and 26.8 percent of isolates, respectively. Clarithromycin and amikacin showed the strongest activity against slow-growing species. Incorporating species-level molecular diagnostics prevents misdiagnosis and improves treatment outcomes.

Keywords: Nontuberculous mycobacteria, Pulmonary disease, Mycobacterium avium complex, Drug susceptibility, Differential diagnosis

Citation: Moloi B, Tremblay R, Lim J (2025). Molecular identification and drug susceptibility patterns of nontuberculous mycobacteria isolated from patients with presumptive pulmonary tuberculosis. African Journal of Infectious Diseases Research, 12(8): 600–606. DOI: 10.46882/AJIDR/148849

Manuscript Timeline: Received: July 08, 2025; Revised: August 08, 2025; Accepted: August 19, 2025; Published: August 28, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 593–599

DOI: 10.46882/AJIDR/148848

Article Type: Epidemiological Study

Title: Seroprevalence, risk factors, and hepatic fibrosis staging of chronic hepatitis C virus infection among people who inject drugs

Names of Authors: Karim El-Sayed¹*, Sofie Van Dijk²

Authors’ Affiliations: ¹Department of Tropical Medicine and Hygiene, Alexandria University, Alexandria, Egypt. ²Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, Netherlands.

Abstract: People who inject drugs bear a disproportionate burden of hepatitis C virus transmission and progressive liver disease. We evaluated anti-HCV seroprevalence, active viremia, and non-invasive liver fibrosis scores among individuals attending harm reduction centers. Blood samples from 335 participants were screened via chemiluminescent immunoassay, quantitative HCV RNA polymerase chain reaction, and transient elastography. Anti-HCV seropositivity was 44.8 percent, with active viremia confirmed in 72.0 percent of seropositive individuals and advanced fibrosis present in 23.1 percent. Needle sharing and incarceration history independently predicted infection. Expanding community-based pan-genotypic direct-acting antiviral therapy and needle exchange programs is vital.

Keywords: Hepatitis C virus, People who inject drugs, Direct-acting antivirals, Liver fibrosis, Harm reduction

Citation: El-Sayed K, Van Dijk S (2025). Seroprevalence, risk factors, and hepatic fibrosis staging of chronic hepatitis C virus infection among people who inject drugs. African Journal of Infectious Diseases Research, 12(8): 593–599. DOI: 10.46882/AJIDR/148848

Manuscript Timeline: Received: July 05, 2025; Revised: August 05, 2025; Accepted: August 17, 2025; Published: August 25, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 586–592

DOI: 10.46882/AJIDR/148847

Article Type: Research Article

Title: Antimicrobial resistance profiles and virulence gene distribution among uropathogenic Escherichia coli isolated from pregnant women with asymptomatic bacteriuria

Names of Authors: Amina Yusuf¹*, Filippo Rossi², Camila Rojas³

Authors’ Affiliations: ¹Department of Medical Microbiology, Bayero University Kano, Kano, Nigeria. ²Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. ³Department of Microbiology, University of Chile, Santiago, Chile.

Abstract: Untreated asymptomatic bacteriuria during pregnancy increases risks of acute pyelonephritis, preterm birth, and low birth weight. We assessed the prevalence, phylogenetic groups, virulence factors, and antibiotic susceptibility of uropathogenic Escherichia coli among antenatal attendees. Midstream urine cultures from 540 pregnant women yielded 68 E. coli isolates, which underwent disk diffusion testing and multiplex polymerase chain reaction for fimH, papC, and hlyA genes. Asymptomatic bacteriuria prevalence was 12.6 percent, with E. coli accounting for 66.7 percent of infections and phylogroup B2 predominating. High resistance to ampicillin and trimethoprim-sulfamethoxazole was observed, while nitrofurantoin and fosfomycin remained highly active.

Keywords: Asymptomatic bacteriuria, Escherichia coli, Pregnancy, Virulence factors, Antimicrobial susceptibility

Citation: Yusuf A, Rossi F, Rojas C (2025). Antimicrobial resistance profiles and virulence gene distribution among uropathogenic Escherichia coli isolated from pregnant women with asymptomatic bacteriuria. African Journal of Infectious Diseases Research, 12(8): 586–592. DOI: 10.46882/AJIDR/148847

Manuscript Timeline: Received: July 02, 2025; Revised: August 02, 2025; Accepted: August 14, 2025; Published: August 22, 2025